Volpara to supply breast cancer SW to US Defense Health Agency

Quick Summary:

Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contract from the US Defense Health Agency (DHA).

The contract will see Volpara supply and upgrade breast cancer screening software to the DHA, which provides medical services to millions of active-duty and retired US military personnel and their families.

Under the five-year deal, the DHA will adopt Volpara’s Patient Hub, an AI-powered solution of breast cancer risk assessment and image analysis.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: Economy

Markets: South Korea

Topics: Cancer Contract Health Korean Breast Subsidiary Volpara’s Military Volpara Company Lunit

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-05 @ 12:19:08 (2 weeks ago)

News Timezone: GMT +8:00

News Source URL: kedglobal.com

Language: English

Article Length: 129 words

Reading Time: 1 minutes read

Sentences: 12 lines

Sentence Length: 11 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Korea Economic Daily

News ID: 23420760

View Article Analysis

About Korea Economic Daily

Main Topics: Economy

Official Website: kedglobal.com

Update Frequency: 15 posts per day

Year Established: 1964

Headquarters: South Korea

News Last Updated: 7 hours ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #91

Publisher Details

Frequently Asked Questions